↑ |
increased |
↓ |
reduced |
ACR |
American College of Rheumatology |
AGEs |
advanced glycation end products |
AI |
adequate intake |
ASU |
avocado–soybean unsaponifiable extracts |
BCAAs |
branched-chain amino acids |
DHA |
docosahexaenoic acid |
EFSA |
European Food Safety Authority |
EPA |
eicosapentaenoic acid |
ESCEO |
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases |
EULAR |
European Alliance of Associations for Rheumatology |
IL-1 |
interleukin 1 |
IL-10 |
interleukin 10 |
IL-1β |
interleukin-1 beta |
IL-2 |
interleukin 2 |
INFɣ |
interferon-gamma |
Lequesne index |
presence of pain, discomfort, morning stiffness |
MMP |
matrix metalloproteinases |
MUFAs |
monounsaturated fatty acids |
N |
number of patients |
NSAIDs |
non-steroidal anti-inflammatory drugs |
OA |
osteoarthritis |
OARSI |
Osteoarthritis Research Society International |
PUFAs |
polyunsaturated fatty acids |
RCTs |
randomized controlled trials |
RDA |
Recommended Dietary Allowance |
ROS |
reactive oxygen species |
SFAs |
saturated fatty acids |
ss |
statistically significant |
SYSADOAs |
symptomatic slow-acting drugs |
TNFα |
tumor necrosis factor-alpha |
WOMAC |
Western Ontario, and McMaster University Universities Osteoarthritic Index |
YLD |
years lived with disability |